Ohno, 1992 - Google Patents
Of palindromes and peptidesOhno, 1992
- Document ID
- 3678375262175820305
- Author
- Ohno S
- Publication year
- Publication venue
- Human genetics
External Links
Snippet
On the average, 30% of the residues in a protein are members of peptidic palindromes, tripeptidic and longer. This percentage may go up to 50% in histones and certain other DNA binding proteins. The longest peptidic palindrome encountered thus far was 14 residues in …
- 108090000765 processed proteins & peptides 0 title description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ragot et al. | Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice | |
| Cantatore et al. | The complete nucleotide sequence, gene organization, and genetic code of the mitochondrial genome of Paracentrotus lividus | |
| Porterfield et al. | Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity | |
| Eppler et al. | Nucleotide sequence of the bacteriophage P22 genes required for DNA packaging | |
| Shlomai | The structure and replication of kinetoplast DNA | |
| Van der Vliet | Adenovirus DNA replication | |
| EP0038765B1 (en) | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine | |
| EP2966170A1 (en) | HBV inactivation | |
| WO2023024500A1 (en) | Constructs and methods for preparing circular rna | |
| IL173399A0 (en) | Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy | |
| KR20030009429A (en) | Hepatitis b core antigen fusion proteins | |
| CN101616685A (en) | Unstructured recombinant polymers and its application | |
| Rumlova-Klikova et al. | Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape | |
| US20240327847A1 (en) | Compositions and methods for rna affinity | |
| Dalziel et al. | The nuclear autoimmune antigen Ku is also present on the cell surface | |
| Ohno | Of palindromes and peptides | |
| IL305421A (en) | Engineered expression vectors for increasing synthetic mRNA expression | |
| Hillebrandt et al. | Process development for cross‐flow diafiltration‐based VLP disassembly: A novel high‐throughput screening approach | |
| Ulbrich et al. | Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins | |
| CN101091797B (en) | Method for taking off endotoxin in primary pure plasmids or proteins, and kit | |
| Wang et al. | DNA helicase and duplex DNA fragment unwinding activities of polyoma and simian virus 40 large T antigen display similarities and differences | |
| Saier Jr et al. | Statistical and functional analyses of viral and cellular proteins with N-terminal amphipathic alpha-helices with large hydrophobic moments: importance to macromolecular recognition and organelle targeting | |
| TW202221126A (en) | Methods of identifying and characterizing anelloviruses and uses thereof | |
| US20240091343A1 (en) | Technology platform of uncapped-linear mrna with unmodified uridine | |
| JP2022538935A (en) | Prokaryotic-Eukaryotic Hybrid Viral Vectors for Delivery of Large Cargoes of Genes and Proteins into Human Cells |